Enhancing Attention and Wellbeing Using Digital Therapeutics
University of California, San Francisco · with National Institute on Aging (NIA) · NCT06397469
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 60–99 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 4000
- US sites recruiting
- 1
- Study start
- April 1, 2024
- Record last updated
- August 24, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goals of the proposed research are to first determine the minimal and/or optimal dose of a digital intervention required for cognitive enhancement, and then to examine the impact of several potential moderators of treatment effects (i.e., cognitive decline, AD polygenic hazard score, cardiovascular risk, and race/ethnicity). This knowledge gained from his high-impact study with transform the field of cognitive interventions, paving the way for a precision medicine model for cognitive enhancing interventions that improve quality of life for older adults and individuals with cognitive deficits at risk of developing dementia.
Being studied: MediTrain; Worder
Conditions: Aging; MCI; Cognitive Decline
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- 60+ years old (adult)
- English language fluency
- owning a smartphone or tablet
Exclusion Criteria
- Under 60 years old (minor)
Recruiting US locations
University of California San Francisco
San Francisco, CA 94158
Site contact: David Ziegler, PhD · 415-476-2164 · david.ziegler@ucsf.edu
Study contacts (from the official record)
- David Ziegler, PhD · 4154762164 · david.ziegler@ucsf.edu
- Monique de Villa, MS, MPH · 209-233-3878 · meditrain@ucsf.edu
Similar studies in California
All neurology studies in California →- RecruitingHealthy volunteersPhase 1
A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
Eli Lilly and Company
- Location
- Los Alamitos, CA + 7 other US sites
- Eligibility basics
- Ages 30–85
- RecruitingHealthy volunteersPhase 1
A Study to Evaluate the Drug Levels, Absolute Bioavailability, Safety, Tolerability, and Immunogenicity of Single-Dose of BMS-986446 in Healthy Adults After Single-dose Administration, and Participants With Early…
Bristol-Myers Squibb
- Location
- Anaheim, CA
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1
A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
Eli Lilly and Company
- Location
- Los Alamitos, CA + 5 other US sites
- Eligibility basics
- Ages 45–85
- RecruitingHealthy volunteersPhase 1/Phase 2
Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
Ashvattha Therapeutics, Inc.
- Location
- San Francisco, CA + 2 other US sites
- Eligibility basics
- Ages 18–80